Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN7 | P35236 | 5/20 | 0.50 |
| ▸ | RECQL | P46063 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.50 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | HMGCR | P04035 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4969753 | 0.93 | PTPN7 (0.57) | PTPN7RECQLTDP1MAPTBLM | |
| SCHEMBL31520020 | 0.91 | PTPN7 (0.61) | PTPN7RECQLTDP1MAPTBLM | |
| SCHEMBL31520018 | 0.91 | PTPN7 (0.61) | PTPN7RECQLTDP1MAPTBLM | |
| SCHEMBL31520017 | 0.91 | PTPN7 (0.61) | PTPN7RECQLTDP1MAPTBLM | |
| SCHEMBL30966140 | 0.91 | PTPN7 (0.61) | PTPN7RECQLTDP1MAPTBLM | |
| SCHEMBL31520015 | 0.91 | PTPN7 (0.61) | PTPN7RECQLTDP1MAPTBLM | |
| SCHEMBL31520016 | 0.91 | PTPN7 (0.61) | PTPN7RECQLTDP1MAPTBLM | |
| SCHEMBL31520019 | 0.91 | PTPN7 (0.61) | PTPN7RECQLTDP1MAPTBLM | |
| SCHEMBL31520021 | 0.91 | PTPN7 (0.61) | PTPN7RECQLTDP1MAPTBLM | |
| SCHEMBL29242822 | 0.91 | PTPN7 (0.61) | PTPN7RECQLTDP1MAPTBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119912668-A | Synthesis of linear aliphatic polyesters | 丰益国际有限公司 | 2025-05-02 | — | — | CN | disclosed |
| EP-3258929-B1 | FACTOR IXA INHIBITORS | MERCK SHARP & DOHME (US) | 2022-04-27 | — | — | EP | disclosed |
| US-10351558-B2 | Factor IXa inhibitors | MERCK SHARP & DOHME CORP. (US) | 2019-07-16 | — | — | US | disclosed |
| US-20180022747-A1 | Factor IXa Inhibitors | MERCK SHARP & DOHME CORP. (US) | 2018-01-25 | — | — | US | disclosed |
| EP-3258929-A1 | FACTOR IXa INHIBITORS | Merck Sharp & Dohme Corp. (US) | 2017-12-27 | — | — | EP | disclosed |
| WO-2016133793-A1 | FACTOR IXa INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2016-08-25 | — | — | WO | disclosed |
| EP-0980016-B1 | ALIGNING AGENT FOR LIQUID CRYSTAL | NISSAN CHEMICAL IND LTD (JP) | 2008-09-24 | — | — | EP | disclosed |
| EP-0980016-A1 | ALIGNING AGENT FOR LIQUID CRYSTAL | Nissan Chemical Industries, Ltd. (JP) | 2000-02-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180022747-A1 | Factor IXa Inhibitors | F9, TFPI, F12 | PTPN7 3677/4885RECQL 1467/4885TDP1 4008/4885 |
| US-10351558-B2 | Factor IXa inhibitors | F9, TFPI, F12 | PTPN7 3677/4885RECQL 1467/4885TDP1 4008/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.